ONDANSETRON HYDROCHLORIDE DIHYDRATE - Výsledky vyhľadávania

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

zofran ondansetron (as hydrochloride dihydrate) 4mg tablet blister pack

aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; hypromellose - ondansetron (tablets, syrup, wafers, suppository and injection) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

ondansetron kabi

fresenius kabi new zealand limited - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml; - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection - ondansetron injection is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

apo-ondansetron

ipca pharma (nz) pty limited - ondansetron hydrochloride dihydrate 5mg equivalent to ondansetron 4 mg; - film coated tablet - 4 mg - active: ondansetron hydrochloride dihydrate 5mg equivalent to ondansetron 4 mg excipient: hypromellose iron oxide yellow lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water titanium dioxide - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. also indicated for the prevention of post-operative nausea and vomiting

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

apo-ondansetron

ipca pharma (nz) pty limited - ondansetron hydrochloride dihydrate 10mg equivalent to ondansetron 8 mg; - film coated tablet - 8 mg - active: ondansetron hydrochloride dihydrate 10mg equivalent to ondansetron 8 mg excipient: hypromellose iron oxide yellow lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water titanium dioxide - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. also indicated for the prevention of post-operative nausea and vomiting